Cargando…
Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
Liquid biopsy represents a valid strategy for tumor molecular characterization. It gives the opportunity to bypass tumor heterogeneity, to monitor tumor characteristics during the course of treatment, and to perform the analysis even when tumor tissue is not available or inadequate. In the clinical...
Autores principales: | Ulivi, Paola, Passardi, Alessandro, Marisi, Giorgia, Chiadini, Elisa, Molinari, Chiara, Canale, Matteo, Pasini, Luigi, Ferroni, Fabio, Frassineti, Giovanni Luca, Bartolini, Giulia, Monti, Manlio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631449/ https://www.ncbi.nlm.nih.gov/pubmed/34858176 http://dx.doi.org/10.3389/fphar.2021.745701 |
Ejemplares similares
-
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy
por: Ulivi, Paola, et al.
Publicado: (2017) -
Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer
por: Canale, Matteo, et al.
Publicado: (2021) -
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
por: Ulivi, Paola, et al.
Publicado: (2018) -
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer
por: Marisi, Giorgia, et al.
Publicado: (2023) -
Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients
por: Pirini, Francesca, et al.
Publicado: (2020)